Impressive Objective Response to Nab-Paclitaxel plus Trastuzumab as Fifth Line Therapy in an Elderly HER-2 Positive Breast Cancer Patient

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Impressive Objective Response to Nab-Paclitaxel plus Trastuzumab as Fifth Line Therapy in an Elderly HER-2 Positive Breast Cancer Patient"
written by Maria Rosaria Valerio, Chiara Ancona, Antonella Marchese, Vittorio Gebbia,
published by Journal of Cancer Therapy, Vol.8 No.11, 2017

has been cited by the following article(s):

[1]	A Focus on “Bio” in Bio–Nanoscience: The Impact of Biological Factors on Nanomaterial Interactions
	2021

[2]	The influence of female mice age on biodistribution and biocompatibility of citrate-coated magnetic nanoparticles
	2019

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top